Tulsa, OKNCT04944979Now EnrollingIRB Ready

Primary Immunodeficiency Disease Clinical Trial in Tulsa, OK

Access cutting-edge primary immunodeficiency disease treatment through this clinical trial at a research site in Tulsa. Study-provided care at no cost to qualified participants.

Sponsored by Kedrion S.p.A.

Quick Self-Assessment

See if you qualify for this Tulsa location

Preparing your pre-screening questions...

Expert Care in Tulsa

Access primary immunodeficiency disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary immunodeficiency disease treatment provided free

Apply for This Tulsa Location

Check if you qualify for this primary immunodeficiency disease clinical trial in Tulsa, OK

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tulsa

    Convenient for OK residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tulsa site if eligible
  4. 4Begin participation

About This Primary Immunodeficiency Disease Study in Tulsa

The purpose of this study is to assess efficacy, safety and pharmacokinetics of Kedrion Immunoglobulin 10% (KIg10) in pediatric patients with Primary Immunodeficiency Disease (PID).

Sponsor: Kedrion S.p.A.

Who Can Participate

Inclusion Criteria

Written informed consent/assent obtained from the patient and his/her parent(s) or legally acceptable representative indicating that they understand the purpose of and procedures required for the study and are willing to participate in it. 2. Confirmed clinical diagnosis of a PID as defined by 2017 International Union of Immunological Societies (IUIS) Phenotypic Classification for Primary Immunodeficiencies (Bousfiha A, 2018 - and subsequent revisions) and The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity (Seidel MG et al., 2019 - and subsequent revisions) and requiring treatment with IVIg. Documented agammaglobulinemia (defined as the total absence of one or more classes of antibodies) or hypogammaglobulinemia (defined as low levels of one or more classes \[i.e., at least 2 standard deviations under the mean level per age\]). (NOTE: IVIg treatment is generally requested in

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tulsa?

Yes, this clinical trial (NCT04944979) has an active research site in Tulsa, OK that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Immunodeficiency Disease Treatment Options in Tulsa, OK

If you're searching for primary immunodeficiency disease treatment options in Tulsa, OK, this clinical trial (NCT04944979) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tulsa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary immunodeficiency disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary immunodeficiency disease clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Tulsa, OK

See all multiple myeloma clinical trials recruiting in Tulsa — not just this study.

Browse Multiple Myeloma Trials in Tulsa →

Browse More Trials by Condition

Multiple Myeloma TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Tulsa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tulsa, OK